WHO Warns of High Risk of Polio Virus Spreading Across Gaza, Assessment Underway
The World Health Organization (WHO) has issued a stark warning that the Gaza Strip now faces a serious threat of large-scale transmission of the polio virus. The warning follows an in-depth analysis of the local public health situation, and WHO is currently conducting a comprehensive assessment and study of the issue.
According to the WHO, a number of suspected polio cases have recently been reported in the Gaza Strip, which is of great concern to global health experts. Polio, also known as poliomyelitis, is a highly contagious viral disease that, once it breaks out in a community, can spread rapidly, posing a deadly threat to unvaccinated children. Based on historical data, the virus can cause permanent paralysis and even, in the most severe cases, death.
In response to this crisis, WHO is working closely with the health authorities in the Gaza Strip to assess the severity of the outbreak and urgently develop a response strategy. A team of international experts is conducting in-depth research to determine how best to stop the spread of the virus within high-risk areas. This includes strengthening surveillance systems to ensure timely detection and isolation of cases, and expanding vaccination coverage, especially among children.
At the same time, WHO has issued an urgent appeal to the international community to provide the necessary financial and technical support to strengthen the vaccination programme and public health infrastructure in the Gaza Strip. WHO stressed that only through global solidarity and sustained efforts can effectively stop the spread of polio and protect the health and safety of the region, especially children.
This warning once again highlights the importance of global public health security and the need for collective action in responding to infectious disease threats. In 2019, the number of polio cases worldwide rebounded to 122, indicating that we still face significant challenges in achieving the goal of global polio elimination. Therefore, the international community must be vigilant and work together to increase global vaccination coverage to prevent the recurrence of this preventable disease.
Looking for chemical products? Let suppliers reach out to you!
2026-06-10
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
Glenmark Recalls Over 110000 Bottles of BP and COPD Drugs in US Due to Safety Concerns
-
Parliamentary Panel Urges Expanded Price Controls as Dozens of Cancer Drugs Remain Unregulated
-
Novo Nordisk Reports Theft of Six Drug Batches in India Authorities Warn of Severe Patient Safety Risks
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
Lilly’s U.S. API Investment Highlights a New Phase of Pharma Supply Localization
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
Pfizer Lifts 2025 Profit Forecast After Q2 Earnings Beat Sales Hit $14.65 Billion Shares Jump 2.8 Percent
-
Sandoz Set to Slash Canadian Weight-loss Drug Prices by Up to 70 Percent Generics Could Expand Patient Access
Recommend Reading
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
Over 100 Foreign Pharma Executives Join Chinese Firms in 5 Years Industry Faces Key Challenges
-
Merck’s New CMV Drug Approved in China Targets Nearly 40000 HSCT Patients
-
FDA Approves Datopotamab Deruxtecan for Second Indication 45 Percent Response Rate in EGFR Mutant Lung Cancer
-
UK Parliament Approves Assisted Dying Bill 7500 Could Seek Euthanasia Annually
-
Supporting Easing This Week, Shandong Normal Butanol Market Weakly Operates
-
Sodium Metabisulfite Prices Rise This Week in China (4.13-4.17)
-
The market price of propylene oxide shows a differentiated pattern of short-term low and medium-to-long-term medium-high positions in China
-
This week, the Aniline market in China saw a slight increase (4.13-4.17)
-
Cost Relaxation, Butylenes Market in Downward Trend